JPRN-UMIN000040040
Completed
N/A
Multicenter retrospective study focusing on efficacy and safety of Omidenepag isopropyl - Multicenter retrospective study of Omidenepag isopropyl
ConditionsGlaucoma or Ocular hypertension
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Glaucoma or Ocular hypertension
- Sponsor
- Santen Pharmaceutical Co. Ltd.
- Enrollment
- 827
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Refer to paper
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •There is no exclusion criteria in this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
A Multi-center Retrospective Study With Secondary Use of Data of Tafinlar (Dabrafenib) Plus Mekinist (Trametinib) in Chinese Patients With BRAF V600 Mutation Positive MelanomaBRAF V600 Mutation Positive MelanomaNCT06337617Novartis Pharmaceuticals90
Completed
N/A
Multicenter prospective study to assess the efficacy of macroscopic on-site quality evaluation during EUS-FNBJPRN-UMIN000036528Shizuoka Cancer Center108
Not Yet Recruiting
N/A
Multi-center retrospective study on efficacy and safety of new-generation microwave ablation in patients with hepatocellular carcinomaJPRN-UMIN000052612Keio University2,200
Completed
N/A
An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 InfectionHIV InfectionsNCT01902615Hoffmann-La Roche58
Completed
N/A
Multicenter retrospective study to examine the efficacy of intervention by healthcare providers for hand-foot skin reaction that occurred after sorafenib use for patients with advanced hepatocellular carcinomaJPRN-UMIN000038701Hitachi General Hospital130